A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
2020 · Nature Communications · 239 citations
https://doi.org/10.1038/s41467-020-18546-x
M
Ming You
Fudan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
390
Papers
12.9K
Citations
57
h-index
182
i10-index
Ming You is an academic researcher from Fudan University. The author has contributed to research in topics: RNA modifications and cancer & Lung Cancer Treatments and Mutations & Cancer-related Molecular Pathways. The author has an h-index of 57, co-authored 332 publications.
ORCID: 0000-0002-9741-268XPapers by this author
worksTargeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
2019 · Nature Communications · 232 citations
https://doi.org/10.1038/s41467-019-10042-1
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
2012 · Carcinogenesis · 205 citations
https://doi.org/10.1093/carcin/bgs148
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer
2019 · Cell Reports · 94 citations
https://doi.org/10.1016/j.celrep.2019.11.085
Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents
2020 · Cancer Prevention Research · 85 citations
https://doi.org/10.1158/1940-6207.capr-20-0425
Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
2014 · BMC Medical Genomics · 72 citations
https://doi.org/10.1186/1755-8794-7-32
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat